Follow-The-Filings

AVTX Avalo Therapeutics

Avalo Therapeutics earnings company data as of 4:47 AM ET 9/29

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period · newest first · EPS & Rev stacked · nothing reported yet

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR · 9 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01
10-Q
424B3
8-K 5.02
8-K 8.01,9.01
8-K 3.02,3.03,5.02,5.03,9.01
8-K 5.02,5.07,9.01
8-K 2.02,9.01
10-Q

Insider forms

Form 3 / 4 / 5 from EDGAR · 4 rows shown

Filed Form Detail Links
4 Period Sep 16, 2026
4 Period Sep 10, 2026
4 Period Aug 28, 2026
4 Period Aug 17, 2026 · 2 forms

20 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice